<DOC>
	<DOCNO>NCT00595270</DOCNO>
	<brief_summary>The study investigate long term persistence Japanese encephalitis vaccine IC51 need booster dose</brief_summary>
	<brief_title>Long Term Persistence Effect Booster Dose Japanese Encephalitis Vaccine IC51</brief_title>
	<detailed_description>This open label , non‐randomized multi‐center phase 3 follow‐up study . All volunteer complete trial IC51‐304 ( NCT00595790 ) enrol trial 2 site</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least 18 year age Written inform consent obtain prior study entry Subjects correctly include complete study IC51304 accord protocol . Use investigational nonregistered drug vaccine addition study vaccine study period Immunodeficiency include postorgantransplantation immunosuppressive therapy Pregnancy , lactation unreliable contraception female subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>